Literature DB >> 25193630

Case fatality rates of Ebola virus diseases: a meta-analysis of World Health Organization data.

A Lefebvre1, C Fiet1, C Belpois-Duchamp1, M Tiv1, K Astruc1, L S Aho Glélé2.   

Abstract

OBJECTIVE: Our objective was to estimate the case fatality rates of Zaire, Sudan, and Bundibugyo Ebola species, responsible for sometimes-lethal hemorrhagic fevers.
METHODS: We performed a meta-analysis of World Health Organization data on outbreaks of infections due to theses species.
RESULTS: Twenty outbreaks, including the current one, were studied. The estimated case fatality rate was 65.4% (CI 95% [54.6%; 75.5%]) and varied among the outbreaks. A species effect was identified, with a higher case fatality rate for the Zaire species than for Sudan and Bundibugyo species. The case fatality rate of the Zaire species tended to decrease with time.
CONCLUSION: The case fatality rates associated with these 3 species was high. A great variability was observed. It could be explained partly by a species effect and by the decrease of Zaire species case fatality rate, with time.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Case fatality rate; Ebola; Meta-analysis; Méta-analyse; Taux de létalité; Ébola

Mesh:

Year:  2014        PMID: 25193630     DOI: 10.1016/j.medmal.2014.08.005

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  28 in total

1.  Assessing the direct effects of the ebola outbreak on life expectancy in liberia, sierra leone and Guinea.

Authors:  Stephane Helleringer; Andrew Noymer
Journal:  PLoS Curr       Date:  2015-02-19

2.  The predictor of mortality outcome in adult patients with Ebola virus disease during the 2014-2015 outbreak in Guinea.

Authors:  M S Cherif; N Koonrungsesomboon; M P Diallo; E Le Gall; D Kassé; F Cherif; A Koné; M Diakité; F Camara; N Magassouba
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-25       Impact factor: 3.267

3.  Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome System.

Authors:  Corri B Levine; Chad E Mire; Thomas W Geisbert
Journal:  J Virol       Date:  2021-08-11       Impact factor: 5.103

Review 4.  Ebola: a holistic approach is required to achieve effective management and control.

Authors:  Anna Roca; Muhammed O Afolabi; Yauba Saidu; Beate Kampmann
Journal:  J Allergy Clin Immunol       Date:  2015-04       Impact factor: 10.793

5.  Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes.

Authors:  Andrea Rivera; Ilhem Messaoudi
Journal:  ACS Infect Dis       Date:  2015-03-30       Impact factor: 5.084

6.  Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses.

Authors:  Audrey Stéphanie Richard; Adam Zhang; Sun-Jin Park; Michael Farzan; Min Zong; Hyeryun Choe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

7.  Therapeutics for postexposure treatment of Ebola virus infection.

Authors:  Marina Jerebtsova; Sergei Nekhai
Journal:  Future Virol       Date:  2015-03       Impact factor: 1.831

8.  Identification of filovirus entry inhibitors targeting the endosomal receptor NPC1 binding site.

Authors:  Leah Liu Wang; Nicholas Palermo; Leslie Estrada; Colton Thompson; J J Patten; Manu Anantpadma; Robert A Davey; Shi-Hua Xiang
Journal:  Antiviral Res       Date:  2021-03-08       Impact factor: 5.970

9.  A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making.

Authors:  Maria D Van Kerkhove; Ana I Bento; Harriet L Mills; Neil M Ferguson; Christl A Donnelly
Journal:  Sci Data       Date:  2015-05-26       Impact factor: 6.444

10.  Interdisciplinarity and Infectious Diseases: An Ebola Case Study.

Authors:  Vanessa O Ezenwa; Anne-Helene Prieur-Richard; Benjamin Roche; Xavier Bailly; Pierre Becquart; Gabriel E García-Peña; Parviez R Hosseini; Felicia Keesing; Annapaola Rizzoli; Gerardo Suzán; Marco Vignuzzi; Marion Vittecoq; James N Mills; Jean-François Guégan
Journal:  PLoS Pathog       Date:  2015-08-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.